ImmunityBio (IBRX) Debt to Equity (2014 - 2026)

ImmunityBio (IBRX) reported Debt to Equity of -$0.47 for Q1 2026, up 7.29% year-over-year from -$0.43 in Q1 2025, and up 28.28% quarter-over-quarter from -$0.65 in Q4 2025.

ImmunityBio (IBRX) Debt to Equity (2014 - 2026) Analysis & Trends

ImmunityBio (IBRX) has 13 years of Debt to Equity data on file, last reported at -$0.47 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at -$0.47, up 7.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.47 (up 7.29% YoY), and the FY2025 annual result was -$0.65, down 11.32% from the prior year.
  • Debt to Equity advanced to -$0.47 in Q1 2026 per IBRX's latest filing, from -$0.65 in the prior quarter.
  • Over five years, Debt to Equity peaked at -$0.24 in Q1 2024 and troughed at -$1.17 in Q3 2023.
  • A 5-year average of -$0.58 and a median of -$0.54 in 2025 frame the typical range for Debt to Equity.
  • On a YoY basis, Debt to Equity climbed as much as 68.54% in 2024 and fell as far as 119.66% in 2024.
  • A 5-year view of Debt to Equity shows it stood at -$0.87 in 2022, then jumped by 69.51% to -$0.27 in 2023, then slumped by 119.66% to -$0.58 in 2024, then declined by 11.32% to -$0.65 in 2025, then gained by 28.28% to -$0.47 in 2026.
  • Business Quant data shows IBRX's Debt to Equity at -$0.47 in Q1 2026, -$0.65 in Q4 2025, and -$0.6 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 ImmunityBio 7.55 Bn 7.17 Bn 43.97 Mn -0.47

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.47
Dec 31, 2025 -0.65
Sep 30, 2025 -0.60
Jun 30, 2025 -0.54
Mar 31, 2025 -0.50
Dec 31, 2024 -0.58
Sep 30, 2024 -0.37
Jun 30, 2024 -0.38
Mar 31, 2024 -0.24
Dec 31, 2023 -0.27
Sep 30, 2023 -1.17
Mar 31, 2023 -0.46
Sep 30, 2022 -0.87
Jun 30, 2022 -0.74
Mar 31, 2022 -0.92
Sep 30, 2021 -1.64
Jun 30, 2021 -2.00
Mar 31, 2021 -1.70
Dec 31, 2020 -2.27
Sep 30, 2020 -1.01